Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2025-12-25 @ 2:42 AM
NCT ID:
NCT03500133
Eligibility Criteria:
Inclusion Criteria:
* Histopathological diagnosis of classical Hodgkin lymphoma.
* Normal renal, hepatic, pulmonary and metabolic function standards.
* Informed consent signed by patient and/or legal caretakers.
Exclusion Criteria:
* Lymphocyte predominant nodular Hodgkin lymphoma
* Any form of immunodeficiency before diagnosis. (primary immunodeficiencies, trasplant recipients or immunosuppressive therapies of any kind including corticoid therapies during 28 days before diagnosis).
* Pregnancy and breastfeeding period.
* Sexually active female patients who do not accept an effective contraceptive method during therapy.
* Positive HIV serology.
* Penfigus or hepatic ductopenia.
* Hodgkin lymphoma as a secondary malignant disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
18 Years
Study:
NCT03500133
Study Brief:
Protocol Section:
NCT03500133